Prevention of preterm delivery.
Simhan
Hyagriv N
HN
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, USA. hsimhan@mail.magee.edu
Caritis
Steve N
SN
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use; D020030:Nitric Oxide Donors / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011247:Pregnancy; D047928:Premature Birth / Q000517:prevention & control*; D018045:Receptors, Oxytocin / Q000037:antagonists & inhibitors; D012307:Risk Factors; D015145:Tocolysis / Q000379:methods*; D015149:Tocolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists; D015415:Biomarkers; D002121:Calcium Channel Blockers; D016861:Cyclooxygenase Inhibitors; D020030:Nitric Oxide Donors; D018045:Receptors, Oxytocin; D015149:Tocolytic Agents; D008278:Magnesium Sulfate